Award
Delivery Order #75N91026F00032
Multi-Year Delivery Order for Clinical Material Tech by Leidos Biomedical Research
Buyer
National Institutes of Health
Award Amount
$17,712,309.00
Ceiling
$17,712,309.00
Awarded
September 24, 2026
Period of Performance
Sep 24, 2026 – Sep 23, 2031
Identifier
75N91026F00032
NAICS
541715
This award is a multi-year delivery order contract focusing on clinical material technology development and pilot manufacturing. The recipient, Leidos Biomedical Research, Inc., a company specializing in biomedical research and development, is tasked with advancing clinical material technologies crucial for medical research and treatment development. This contract supports significant R&D efforts underpinning health innovations, particularly within the National Cancer Institute's scope. The work under this contract includes development and pilot-scale manufacturing of clinical materials, essential for enabling further research and clinical trials. This contract is a delivery order under a broader, competitively awarded Federally Funded Research and Development Center (FFRDC) contract held by Leidos Biomedical Research Inc. for the NCI, indicating continuity and reliance on proven expertise. Performance is located in Frederick, Maryland, with a substantial timeline covering multiple years, ensuring sustained support for biomedical research initiatives. The award reflects a strategic investment in health sector innovation and leverages Leidos’s established contract infrastructure to meet the program's critical requirements efficiently.
Description
CLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURING